颈动脉干预对无症状颈动脉狭窄患者认知功能影响的系统综述
该系统综述纳入31项非随机研究,评估颈动脉内膜剥脱术(CEA)和颈动脉支架置入术(CAS)对无症状颈动脉狭窄(ACS)患者早期和晚期认知功能的影响。结果显示,晚期认知功能改善和显著下降的比例均低于2%,多数患者认知功能无变化(69%)或仅个别测试改善(24.8%)。缺乏证据支持对ACS患者进行干预以预防或逆转认知下降。
要点
- CEA/CAS后晚期整体认知功能改善罕见(<2%),显著下降风险同样低(<2%)。
- 多数患者晚期认知功能稳定(69%无变化,24.8%仅个别测试改善)。
- 现有证据不支持为预防认知下降而对无症状颈动脉狭窄患者进行干预。
核心结论
- CEA/CAS很少改善ACS患者晚期整体认知功能(<2%),显著认知下降风险同样低(<2%)。
- 长期随访中多数患者认知功能无变化(69%)或仅个别测试改善(24.8%)。
- 缺乏证据支持对ACS患者进行干预以预防或逆转认知下降。
研究设计与样本
- 系统综述纳入31项非随机研究,检索PubMed/Medline、Embase、Scopus和Cochrane图书馆。
临床怎么用
- 对于无症状颈动脉狭窄患者,不应以预防或逆转认知下降为目的而常规推荐CEA或CAS。
- 临床决策应基于其他适应证,认知功能影响不应作为主要考量。
局限性
- 纳入研究均为非随机设计,存在异质性。
- 需要新研究识别易感ACS亚组(如脑血流储备受损)或证实无症状栓塞导致认知障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the effect of carotid endarterectomy (CEA) and carotid artery stenting (CAS) on early (baseline vs. maximum three months) and late (baseline vs. at least five months) cognitive function in patients with exclusively asymptomatic carotid stenoses (ACS). METHOD: Searches were conducted in PubMed/Medline, Embase, Scopus, and the Cochrane library. This systematic review includes 31 non-randomised studies. RESULTS: Early post-operative period: In 24 CEA/CAS/CEA+CAS cohorts (n = 2 059), two cohorts (representing 91/2 059, 4.4% of the overall study population) reported significant improvement in cognitive function, while one (28/2 059, 1%) reported significant decline. Three cohorts (250/2 059, 12.5% reported "mixed findings" where some cognitive scores significantly improved, and a similar proportion declined. The majority (nine cohorts; 1 086/2 059, 53%) reported no change. Seven cohorts (250/2 059, 12.1%) were mostly unchanged but one to two individual test scores improved, while two cohorts (347/2 059, 16.8%) were mostly unchanged with one to two individual test scores worse. Late post-operative period: In 21 cohorts (n = 1 554), one (28/1 554, 1.8%) reported significantly worse cognitive function, one reported significant improvement (24/1 554, 1.5%), while a third (19/1 554, 1.2%) reported "mixed findings". The majority were unchanged (six cohorts; 1 073/1 554, 69%) or mostly unchanged, but with one to two cognitive tests showing significant improvement (11 cohorts; 386/1 554, 24.8%). Overall, there was a similar distribution of findings in small, medium, and large studies, in studies with controls vs. no controls, in studies comparing CEA vs. CAS, and in studies with shorter/longer late follow up. CONCLUSION: Notwithstanding accepted limitations regarding heterogeneity within non-randomised studies, CEA/CAS rarely improved overall late cognitive function in ACS patients (< 2%) and the risk of significant cognitive decline was equally low (< 2%). In the long term, the majority were either unchanged (69%) or mostly unchanged with one to two test scores improved (24.8%). Until new research identifies vulnerable ACS subgroups (e.g., impaired cerebral vascular reserve) or provides evidence that silent embolisation from ACS causes cognitive impairment, evidence supporting intervention in ACS patients to prevent/reverse cognitive decline is lacking.
引用
- Ancetti S, Paraskevas KI, Faggioli G, et al. Editor's Choice - Effect of Carotid Interventions on Cognitive Function in Patients With Asymptomatic Carotid Stenosis: A Systematic Review. Eur J Vasc Endovasc Surg. 2021. PMID: 34474964. doi:10.1016/j.ejvs.2021.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。